Raidt Lena, Idelevich Evgeny A, Dübbers Angelika, Küster Peter, Drevinek Pavel, Peters Georg, Kahl Barbara C
From the *Institute of Medical Microbiology, and †Department of Pediatrics, University Hospital Münster, Münster, Germany; ‡Department of Pediatrics, Clemenshospital Münster, Münster, Germany; and §Department of Medical Microbiology, University Hospital Motol, 2nd Faculty of Medicine, Charles University, Prague, Czech Republic.
Pediatr Infect Dis J. 2015 Jul;34(7):700-5. doi: 10.1097/INF.0000000000000714.
The study objective was to identify changes of prevalence and resistance of important pathogens in specimens of cystic fibrosis (CF) patients within a decade.
Samples of 94 patients, who attended 2 CF centers from 2001 to 2011 were retrospectively analyzed.
Staphylococcus aureus was the most prevalent organism (74.5% in 2011) with an increase of methicillin-resistant S. aureus in patients (0% vs. 9.6%, n = 9). Resistance of S. aureus to gentamicin decreased (41.8% vs. 21%; P < 0.001), whereas resistance to rifampicin and trimethoprim/sulfamethoxazole (P < 0.05) increased significantly with a trend to increased resistance to clindamycin and erythromycin (P = 0.063). Methicillin-resistant S. aureus isolates belonged to 6 spa types (t003, t008, t011, t034, t045, t548). There was a significant increase of Pseudomonas aeruginosa prevalence (63.8% in 2011 vs. 46.8% in 2001, P = 0.019). Resistance of P. aeruginosa increased significantly to imipenem, gentamicin, amikacin, tobramycin, ciprofloxacin and fosfomycin, whereas resistance to piperacillin-tazobactam, meropenem and aztreonam decreased. Significantly fewer Stenotrophomonas maltophilia isolates were susceptible to all the analyzed antibiotics (trimethoprim/sulfamethoxazole, ciprofloxacin and colistin) in 2011 compared with 2001 (13.5% vs. 42.1%; P = 0.023), whereas the resistance to colistin increased significantly (11.1% vs. 62.2%; P < 0.001). Burkholderia cepacia complex and nontuberculous mycobacteria were not detected in 2001 but in 2011 in 7.4% (n = 9) and 7.4% (n = 9) of patients, respectively. B. cepacia complex isolates belonged to 8 multilocus sequence types.
Our retrospective analysis revealed an increase of important CF-related pathogens, the emergence of new pathogens and a substantial increase of multidrug-resistant CF-specific isolates. Our findings are of importance to clinicians for the alertness of local epidemiology, which may be useful for prevention and treatment strategies.
本研究的目的是确定十年间囊性纤维化(CF)患者标本中重要病原体的流行率和耐药性变化。
对2001年至2011年在2个CF中心就诊的94例患者的样本进行回顾性分析。
金黄色葡萄球菌是最常见的病原体(2011年为74.5%),耐甲氧西林金黄色葡萄球菌在患者中的比例增加(0%对9.6%,n = 9)。金黄色葡萄球菌对庆大霉素的耐药性降低(41.8%对21%;P < 0.001),而对利福平及甲氧苄啶/磺胺甲恶唑的耐药性显著增加(P < 0.05),对克林霉素和红霉素的耐药性有增加趋势(P = 0.063)。耐甲氧西林金黄色葡萄球菌分离株属于6种spa型(t003、t008、t011、t034、t045、t548)。铜绿假单胞菌的流行率显著增加(2011年为63.8%,2001年为46.8%,P = 0.019)。铜绿假单胞菌对亚胺培南、庆大霉素、阿米卡星、妥布霉素、环丙沙星和磷霉素的耐药性显著增加,而对哌拉西林-他唑巴坦、美罗培南和氨曲南的耐药性降低。与2001年相比,2011年嗜麦芽窄食单胞菌对所有分析抗生素(甲氧苄啶/磺胺甲恶唑、环丙沙星和黏菌素)敏感的分离株明显减少(13.5%对42.1%;P = 0.023),而对黏菌素的耐药性显著增加(11.1%对62.2%;P < 0.001)。洋葱伯克霍尔德菌复合体和非结核分枝杆菌在2001年未检测到,但在2011年分别在7.4%(n = 9)和7.4%(n = 9)的患者中检测到。洋葱伯克霍尔德菌复合体分离株属于8种多位点序列类型。
我们的回顾性分析显示与CF相关的重要病原体增加、新病原体出现以及CF特异性多重耐药分离株大幅增加。我们的研究结果对临床医生了解当地流行病学情况具有重要意义,这可能有助于预防和治疗策略的制定。